These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 17786634)

  • 41. cDNA-expressed human cytochrome P450 isozymes. Inactivation by porphyrinogenic xenobiotics.
    McNamee JP; Jurima-Romet M; Kobus SM; Marks GS
    Drug Metab Dispos; 1997 Apr; 25(4):437-41. PubMed ID: 9107543
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intersection of the Roles of Cytochrome P450 Enzymes with Xenobiotic and Endogenous Substrates: Relevance to Toxicity and Drug Interactions.
    Guengerich FP
    Chem Res Toxicol; 2017 Jan; 30(1):2-12. PubMed ID: 27472660
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Propofol inhibits renal cytochrome P450 activity and enflurane defluorination in vitro in hamsters.
    Chen TL; Chen TG; Tai YT; Chang HC; Chen RM; Lin CJ; Ueng TH
    Can J Anaesth; 2000 Jul; 47(7):680-6. PubMed ID: 10930209
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibitory monoclonal antibodies to human cytochrome P450 enzymes: a new avenue for drug discovery.
    Gelboin HV; Krausz KW; Gonzalez FJ; Yang TJ
    Trends Pharmacol Sci; 1999 Nov; 20(11):432-8. PubMed ID: 10542439
    [No Abstract]   [Full Text] [Related]  

  • 45. Computational models for predicting interactions with cytochrome p450 enzyme.
    Arimoto R
    Curr Top Med Chem; 2006; 6(15):1609-18. PubMed ID: 16918472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The physiological and pharmacological roles of cytochrome P450 isoenzymes.
    Chang GW; Kam PC
    Anaesthesia; 1999 Jan; 54(1):42-50. PubMed ID: 10209369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recent developments in hepatic drug oxidation. Implications for clinical pharmacokinetics.
    Brosen K
    Clin Pharmacokinet; 1990 Mar; 18(3):220-39. PubMed ID: 2182263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cytochrome P450 networks in chemical space.
    Lee S; Kim D
    Arch Pharm Res; 2010 Sep; 33(9):1361-74. PubMed ID: 20945135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization of cannabidiol-mediated cytochrome P450 inactivation.
    Bornheim LM; Everhart ET; Li J; Correia MA
    Biochem Pharmacol; 1993 Mar; 45(6):1323-31. PubMed ID: 8466552
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes.
    Dhawan A; Parmar D; Dayal M; Seth PK
    Mol Cell Biochem; 1999 Oct; 200(1-2):169-76. PubMed ID: 10569197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Emerging roles for brain drug-metabolizing cytochrome P450 enzymes in neuropsychiatric conditions and responses to drugs.
    Toselli F; Dodd PR; Gillam EM
    Drug Metab Rev; 2016 Aug; 48(3):379-404. PubMed ID: 27498925
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interindividual variation in relative CYP1A2/3A4 phenotype influences susceptibility of clozapine oxidation to cytochrome P450-specific inhibition in human hepatic microsomes.
    Zhang WV; D'Esposito F; Edwards RJ; Ramzan I; Murray M
    Drug Metab Dispos; 2008 Dec; 36(12):2547-55. PubMed ID: 18809730
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Assessment of drug-drug interaction for silymarin.
    Doehmer J; Tewes B; Klein KU; Gritzko K; Muschick H; Mengs U
    Toxicol In Vitro; 2008 Apr; 22(3):610-7. PubMed ID: 18249085
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
    Raner GM; Vaz AD; Coon MJ
    Mol Pharmacol; 1996 Mar; 49(3):515-22. PubMed ID: 8643091
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The human hepatic cytochromes P450 involved in drug metabolism.
    Wrighton SA; Stevens JC
    Crit Rev Toxicol; 1992; 22(1):1-21. PubMed ID: 1616599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of the human cytochromes P450 responsible for atomoxetine metabolism.
    Ring BJ; Gillespie JS; Eckstein JA; Wrighton SA
    Drug Metab Dispos; 2002 Mar; 30(3):319-23. PubMed ID: 11854152
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cytochrome P450-catalyzed pathways in human brain: metabolism meets pharmacology or old drugs with new mechanism of action?
    Haining RL; Nichols-Haining M
    Pharmacol Ther; 2007 Mar; 113(3):537-45. PubMed ID: 17270273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of P450 isozyme-selective inhibitors on in-vitro metabolism of retinoic acid by rat hepatic microsomes.
    Ahmad M; Nicholls PJ; Smith HJ; Ahmadi M
    J Pharm Pharmacol; 2000 Mar; 52(3):311-4. PubMed ID: 10757419
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New findings in studies of cytochromes P450.
    Myasoedova KN
    Biochemistry (Mosc); 2008 Sep; 73(9):965-9. PubMed ID: 18976212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Localization of cytochromes P450 in human tissues: implications for chemical toxicity.
    McKinnon RA; McManus ME
    Pathology; 1996 May; 28(2):148-55. PubMed ID: 8743822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.